{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:51:02Z","timestamp":1791255062201,"version":"4.1.0"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"DOI":"10.1007\/s15010-026-03005-4","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:22:58Z","timestamp":1791192178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Asymptomatic bacteriuria in patients receiving SGLT2 inhibitors: methodological considerations and clinical implications"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7533-8726","authenticated-orcid":false,"given":"Ahmad","family":"Alam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bushra","family":"Amer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"3005_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-026-02905-9","author":"R Hussain","year":"2026","unstructured":"Hussain R, Aslam M, Ashraf H, Khan F. Impact of SGLT2 inhibitors on asymptomatic bacteriuria in T2DM: prevalence, pathogens and risk factors. Infection. 2026. https:\/\/doi.org\/10.1007\/s15010-026-02905-9.","journal-title":"Infection"},{"key":"3005_CR2","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1038\/s41598-017-02733-w","volume":"7","author":"J Liu","year":"2017","unstructured":"Liu J, Li L, Li S, et al. Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis. Sci Rep. 2017;7:2824. https:\/\/doi.org\/10.1038\/s41598-017-02733-w.","journal-title":"Sci Rep"},{"key":"3005_CR3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jcjd.2021.12.005","volume":"46","author":"CV Dave","year":"2022","unstructured":"Dave CV, Schneeweiss S, Kim D, Fralick M, Tong A, Patorno E. Sodium-glucose cotransporter-2 inhibitors and urinary tract infections: a propensity score-matched population-based cohort study. Can J Diabetes. 2022;46:503\u201310. https:\/\/doi.org\/10.1016\/j.jcjd.2021.12.005.","journal-title":"Can J Diabetes"},{"key":"3005_CR4","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1093\/cid\/ciy1121","volume":"68","author":"LE Nicolle","year":"2019","unstructured":"Nicolle LE, Gupta K, Bradley SF, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. Clin Infect Dis. 2019;68:e83\u2013110. https:\/\/doi.org\/10.1093\/cid\/ciy1121.","journal-title":"Clin Infect Dis"},{"key":"3005_CR5","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/dom.13130","volume":"20","author":"GP Fadini","year":"2018","unstructured":"Fadini GP, Bonora BM, Mayur S, Rigato M, Avogaro A. Dipeptidyl peptidase-4 inhibitors moderate the risk of genitourinary tract infections associated with sodium-glucose co-transporter-2 inhibitors. Diabetes Obes Metab. 2018;20:740\u20134. https:\/\/doi.org\/10.1111\/dom.13130.","journal-title":"Diabetes Obes Metab"},{"issue":"Suppl 1","key":"3005_CR6","doi-asserted-by":"publisher","first-page":"bvae163905","DOI":"10.1210\/jendso\/bvae163.905","volume":"8","author":"A Gupta","year":"2024","unstructured":"Gupta A, Singh NK, Phatak S, Singh AN. Real world incidence of urinary tract infections and genital tract infections with SGLT2 inhibitors alone or in combination with DPP4 inhibitors in patients with T2D in India. J Endocr Soc. 2024;8(Suppl 1):bvae163905. https:\/\/doi.org\/10.1210\/jendso\/bvae163.905.","journal-title":"J Endocr Soc"},{"key":"3005_CR7","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.dsx.2020.12.043","volume":"15","author":"BA Laway","year":"2021","unstructured":"Laway BA, Nabi T, Bhat MH, Fomda BA. Prevalence, clinical profile and follow up of asymptomatic bacteriuria in patients with type 2 diabetes\u2014prospective case control study in Srinagar, India. Diabetes Metab Syndr. 2021;15:455\u20139. https:\/\/doi.org\/10.1016\/j.dsx.2020.12.043.","journal-title":"Diabetes Metab Syndr"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-03005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-026-03005-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-026-03005-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:02:54Z","timestamp":1791252174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-026-03005-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":7,"alternative-id":["3005"],"URL":"https:\/\/doi.org\/10.1007\/s15010-026-03005-4","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"6 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}